Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic acid in adult primary biliary cholangitis – phase 3, randomized, double-blind, placebo-controlled trial in China
CTR20211444Phase 3Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of obeticholic acid in primary biliary cholangitis (PBC), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jun 2021; status: completed.
02
Drugs
obeticholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on CTR20211444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211444.